IMR Press / CEOG / Volume 49 / Issue 3 / DOI: 10.31083/j.ceog4903071
Open Access Original Research
Cytoreduction can reduce the recurrence rate of patients with occult uterine sarcoma undergoing morcellation: a retrospective study
Show Less
1 Department of Gynecological Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, 310022 Hangzhou, Zhejiang, China
*Correspondence: (Jianqing Zhu)
Academic Editor: Rafal Watrowski
Clin. Exp. Obstet. Gynecol. 2022, 49(3), 71;
Submitted: 30 November 2021 | Revised: 20 January 2022 | Accepted: 21 January 2022 | Published: 16 March 2022
(This article belongs to the Special Issue Ways of Safety and Individuality in Gynecological Surgery)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

Background: Tumor morcellation happened to facilitate iatrogenic metastasis for patients with occult uterine sarcoma. The optimal completion surgery for these patients needed to be established. Methods: Data were retrospectively collected and analyzed from patients with occult uterine sarcoma undergoing morcellation. Results: 19 consecutive patients with uterine sarcomas undergoing morcellation were accessed between January 2008 and December 2018, including 12 patients with uterine leiomyosarcoma and 7 with endometrial stromal sarcoma. Compared with a simple hysterectomy and individualized surgical resection for suspicious extra-uterine lesions, cytoreduction was significantly associated with a lower recurrence rate (p = 0.017), and none of the seven patients undergoing cytoreduction suffered a recurrence. However, the interval between the initial operation and re-operation, transabdominal route (laparoscopic vs. open surgery), and adjuvant therapy had no such significant difference. Conclusions: Cytoreduction was considered as the optimal completion surgery for patients with occult uterine sarcoma undergoing morcellation.

uterine sarcoma
tumor morcellation
Back to top